Skip to main content

Table 1 Characteristics of patients with OA and RA

From: Decreased Semaphorin3A expression correlates with disease activity and histological features of rheumatoid arthritis

 

OA (n = 23)

RA (n = 30)

Male/female, n

2/21

6/24

Age, mean ± SD (range, years)

76.6 ± 5.8 (64–84)

69.4 ± 8.1 (55–83)

Disease duration, mean ± SD (years)

10.7 ± 5.1

16.3 ± 9.1

CRP, mean ± SD (mg/dl)

0.16 ± 0.30

1.43 ± 1.21

DAS28-CRP, mean ± SD

–

3.74 ± 0.84

Medications

  

Prednisolone, n (%)

NA

17 (56.7)

Methotrexate, n (%)

NA

15 (50.0)

Sulfasalazine, n (%)

NA

7 (23.3)

Bucillamine, n (%)

NA

6 (20.0)

Cyclosporine, n (%)

NA

3 (10.0)

Actarit, n (%)

NA

1 (3.3)

TNF-α blockade, n (%)

NA

4 (13.3)

  1. n, number; OA, osteoarthritis; RA, rheumatoid arthritis; SD, standard deviation; CRP, C-reactive protein; DAS28, 28-joint Disease Activity Score; NA, not applicable.